Jan 20, 2026, 08:51 AM by User Not Found

Bio-IT World | The pharmaceutical industry’s approach to artificial intelligence is maturing, with companies increasingly focused on innovation rather than mere efficiency gains. However, significant hurdles around data quality and workforce training continue to impede progress.

Jan 16, 2026, 07:19 AM by

The PHCbi TwinGuard® ECO freezer ultra-low temperature (ULT) freezer is engineered to deliver enhanced energy efficiency and expanded operational monitoring for biorepositories, biopharmaceutical companies, and academic institutions.

Jan 16, 2026, 07:19 AM by

Jan 16, 2026, 07:19 AM by

Supports customers with real-time clinical intelligence activation through Viz.ai’s integrated clinical workflows, triggers, and compliant orchestration services for Agentforce.

Jan 15, 2026, 08:43 AM by

Sapio Sciences has announced a growing partner ecosystem for Sapio ELaiN, its third-generation AI lab notebook, integrating trusted, third-party scientific applications and platforms directly into the workflow. These integrations allow biopharma scientists to use established tools for modeling, analytics and discovery inside ELaiN while maintaining governance, traceability and control.

Jan 15, 2026, 08:43 AM by

Jan 15, 2026, 08:43 AM by

Jan 14, 2026, 08:53 AM by

Gifthealth has announced the appointment of Jeremy Richardson as its new Chief Commercial Officer (CCO).

Jan 14, 2026, 08:53 AM by

Strategic appointment to support global scale-up of sample management operations

Jan 14, 2026, 08:53 AM by

Jan 14, 2026, 08:53 AM by

Jan 14, 2026, 08:53 AM by

IDT and Ansa announced that Ansa’s Clonal DNA and XL Clonal DNA products, ranging from 100 bp to 50 kb, will be made available to IDT customers. This strategic collaboration enables more researchers to design and assemble longer, more complex constructs for next-generation cell and gene therapy discovery, vaccine research, and agrigenomics applications.

Jan 14, 2026, 01:00 AM by User Not Found

Bio-IT World | At the 44th Annual J.P. Morgan Healthcare Conference, 10x Genomics announced a strong ending to 2025. With great anticipation for 2026, 10x Genomics remains centered on their mission on accelerating understanding of biology to advance human health, particularly in the single-cell and spatial biology areas.

Jan 13, 2026, 17:23 PM by User Not Found

Bio-IT World | Jacob Thaysen returned to the J.P. Morgan Healthcare Conference stage Tuesday with a message of momentum: Illumina is back to growth, and clinical sequencing is driving the train. In his third annual presentation as CEO, Thaysen unveiled preliminary fourth quarter results that exceeded expectations and introduced BioInsight, a new business unit aimed at accelerating drug discovery through AI-powered biological insights.

Jan 13, 2026, 08:46 AM by

Jan 13, 2026, 08:46 AM by

Jan 13, 2026, 08:39 AM by User Not Found

Bio-IT World | PacBio president Christian Henry presented at the 44th Annual J.P. Morgan Healthcare Conference with strong fourth quarter growth, breakthrough clinical adoption, and economics that position long-read sequencing as competitive with short reads.

Jan 12, 2026, 19:35 PM by User Not Found

Bio-IT World | Gordon Sanghera, CEO, presented on behalf of Oxford Nanopore Technologies at the 44th Annual J.P. Morgan Healthcare Conference this week in San Francisco. In what he described as his final appearance at JPM as CEO, Sanghera reflected on 20 years of building a company around single-molecule electronic sensing while outlining a growth trajectory that saw the company exceed expectations in 2025.

Jan 12, 2026, 10:09 AM by User Not Found

Bio-IT World | NVIDIA is making a massive push into healthcare and life sciences, announcing a landmark five-year, $1 billion strategic partnership with pharmaceutical giant Eli Lilly alongside major expansions of its biological AI platform at the 2026 J.P. Morgan Healthcare Conference.

Jan 12, 2026, 09:02 AM by